Skip to main content

DaVita Value Stock - Dividend - Research Selection

DaVita

ISIN: US23918K1088, WKN: 897914

Market price date: 22.05.2020
Market price: 76,81 USD




DaVita Fundamental data and company key figures of the share

Annual reports in USD
Key figures 23-02-2020
Cash flow
Net operating cash flow 2.072.350.000
Capital Expenditures -766.546.000
Free cash flow 1.305.804.032
Balance sheet
Total Equity 2.133.410.000
Liabilities & Shareholders equity 17.311.400.000
Income statement
Net income 810.981.000
Eps (diluted) 5,270
Diluted shares outstanding 153.886.000
Net sales/revenue 11.388.500.000

Fundamental ratios calculated on: 22-05-2020

Ratios
Key figures 22-05-2020
Cash flow
P/C 5,70
   
P/FC 9,05
Balance sheet
ROI4,69
ROE12,32
Income statement
P/E14,58
Div. Yield0,00%
P/B5,54
P/S1,04


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolDVA
Market Capitalization11.819.983.872,00 USD
CountryUnited States
IndicesS&P 500
SectorsHealth service
Raw Data SourceUS GAAP in Millionen USD
Stock Split2013-09-09,2.0000/1.0000; 2004-06-16,3.0000/2.0000; 1997-10-21,5.0000/3.0000
Internetwww.davita.com


Description of the company

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company operates DaVita Rx, a pharmacy that provides oral medications and medication management services to patients with ESRD; disease management services; vascular access services; clinical research programs; physician services; and direct primary care services. As of December 31, 2017, it provided dialysis and administrative services in the United States through a network of 2,510 outpatient dialysis centers serving approximately 197,800 patients; and operated 237 outpatient dialysis centers located in 11 countries outside of the United States. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.davita.com